Wen Tian | Biodegradable composite materials | Best Researcher Award

Dr. Wen Tian, Institute of Subtropical Agriculture Chinese Academy of Sciences, China.

Dr. Wen Tian is a dedicated researcher at the Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, China. His expertise lies in animal nutrition, metabolism, and immunology, focusing on dairy and livestock health . His research spans amino acid metabolism, gut microbiota, and immune responses in livestock . Dr. Tian has contributed to high-impact journals such as the Journal of Dairy Science and Animal Nutrition. His work enhances sustainable animal agriculture by optimizing dietary formulations and improving livestock health and productivity.

Publivation Profiles

SCOPUS

Education and Experience

Ph.D. in Animal Nutrition
M.Sc. in Animal Science
B.Sc. in Animal Husbandry

Researcher at the Key Laboratory of Agro-ecological Processes, Institute of Subtropical Agriculture, CAS, China
Published multiple research papers on dairy cow metabolism, amino acid utilization, and gut microbiota
👨‍🏫 Collaborator in international research on animal nutrition and physiology

Suitability summary

Dr. Wen Tian, a distinguished researcher at the Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, is honored with the Best Researcher Award for his groundbreaking contributions to animal nutrition, metabolic physiology, and livestock health. His extensive research on amino acid metabolism, intestinal health, immune responses, and gut microbiota has significantly advanced livestock science and sustainable agricultural practices.

Professional Development

Dr. Wen Tian continuously advances his expertise in animal metabolism, nutrition, and immune regulation. His work explores the effects of essential amino acids, fatty acids, and dietary supplements on milk production, metabolic efficiency, and gut health in livestock . He is engaged in international collaborations to develop innovative feeding strategies for dairy cows and piglets, ensuring sustainable and efficient livestock farming . His research also integrates circadian rhythm studies in animal physiology . By contributing to peer-reviewed journals and attending global conferences, Dr. Tian remains at the forefront of agricultural biosciences.

Research Focus

Dr. Wen Tian’s research revolves around animal nutrition, metabolism, and immune function . His studies aim to enhance milk protein synthesis, amino acid balance, and dietary efficiency in dairy cows . He investigates the role of fatty acids and gut microbiota in animal growth and health . His work on immune modulation and inflammatory stress contributes to improved animal welfare and sustainable livestock management . By integrating nutritional biochemistry, immunology, and microbiome research, Dr. Tian develops innovative feeding strategies to optimize livestock production and overall animal health.

Awards And Honours

Best Research Paper Award – Journal of Dairy Science (2020)
Outstanding Young Researcher Award – Institute of Subtropical Agriculture, CAS (2021)
Excellence in Animal Nutrition Research – National Livestock Nutrition Conference (2022)
Research Fellowship – Chinese Academy of Sciences (2023)
Top Cited Paper Recognition – Animal Nutrition Journal (2023)

Publication Top Noted

(2017) – Milk protein responses to balanced amino acid and removal of Leucine and Arginine supplied from jugular-infused amino acid mixture in lactating dairy cows – Journal of Animal Physiology and Animal Nutrition – Cited by: 15

(2017) – Responses of milk production of dairy cows to jugular infusions of a mixture of essential amino acids with or without exclusion leucine or arginine – Animal Nutrition – Cited by: 11

(2018) – Jugular arginine infusion relieves lipopolysaccharide-triggered inflammatory stress and improves immunity status of lactating dairy cows – Journal of Dairy Science – Cited by: 33

(2020) – Ruminal epithelial cell proliferation and short-chain fatty acid transporters in vitro are associated with abundance of period circadian regulator 2 (PER2) – Journal of Dairy Science – Cited by: 9

Mohamed Maher | Material Science | Impactful Research Award

Dr. Mohamed Maher, University of Texas Southwestern Medical Center, United States.

Mohamed Maher is a distinguished cancer researcher and clinical pharmacist at MD Anderson Cancer Center, Houston, TX, specializing in genomic test development for liquid biopsies, solid tumors, and hematological malignancies. With a profound background in molecular biology, he optimizes cutting-edge diagnostic tools for clinical applications in collaboration with the Molecular Diagnostic Laboratory. His expertise spans cancer biology, virology, and immunology, supported by advanced research in cholangiocarcinoma and lung cancer. Dedicated to bridging research and practical application, Mohamed is committed to advancing cancer diagnostics to contribute toward the goal of ending cancer.

Education and Experience

Education

Ph.D. in Cancer Biology (Molecular Virology and Immunology) – National Cancer Institute, Cairo University, Egypt (2011–2017)
M.Sc. in Pharmaceutical Sciences (Microbiology and Immunology) – Assiut University, Egypt (2006–2010)
B.Sc. in Pharmaceutical Sciences – Assiut University, Egypt (1998–2003)

Experience

Senior Research Assistant – MD Anderson Cancer Center, Houston, TX (2022–Present)
Postdoctoral Fellow – MD Anderson Cancer Center, Houston, TX (2019–2022)
Lecturer of Cancer Biology, Virology, and Immunology – South Egypt Cancer Institute, Assiut University, Egypt (2017–Present)
Assistant Lecturer – South Egypt Cancer Institute, Assiut University, Egypt (2015–2017)

Suitability For The Award

Dr. Mohamed Maher stands as a distinguished cancer researcher whose transformative contributions to molecular diagnostics and cancer genomics make him an ideal candidate for the prestigious Impactful Research Award. His innovative work in cancer genotyping, particularly in liquid biopsies, solid tumors, and hematological malignancies, underscores his dedication to advancing diagnostic precision and improving patient outcomes. Dr. Maher’s expertise, blending his background as a Clinical Pharmacist, Cancer Biologist, and Molecular Diagnostic innovator, highlights his remarkable ability to translate cutting-edge research into real-world clinical applications, creating a lasting impact in cancer research and diagnostics.

Professional Development

Mohamed Maher’s career is defined by his pursuit of innovation and excellence in cancer research. He is proficient in genomic testing, employing advanced platforms like Illumina NovaSeq 6000 and Ion Torrent systems for molecular diagnostics. His commitment extends to mentoring and teaching, inspiring future scientists in cancer biology, virology, and immunology. With a collaborative spirit, Mohamed integrates laboratory research with clinical practice, emphasizing translational science to develop practical solutions for cancer diagnostics. His dedication to advancing healthcare makes him a driving force in molecular pathology and cancer biology.

Research Focus

Mohamed Maher’s research focuses on the molecular diagnostics of cancer, particularly in developing genomic tests for liquid biopsies, solid tumors, and hematological malignancies. He explores genetic and epigenetic mechanisms in cholangiocarcinoma and lung cancer using innovative platforms and techniques. His work also includes analyzing DNA, RNA, and miRNA biomarkers for early cancer detection and immune repertoire sequencing. Mohamed is dedicated to enhancing molecular profiling methods for personalized cancer treatment, aiming to revolutionize cancer diagnostics and therapeutic strategies.

Awards and Honors

Best Research Abstract Presentation – MD Anderson Cancer Center
Postdoctoral Excellence Award – Recognized for impactful research in cancer biology
Distinguished Teaching Award – South Egypt Cancer Institute
Clinical Pharmacist of the Year – Assiut University
Travel Grant Recipient – International Cancer Research Conferences

Publications Top Notes

“A rapid turnaround time workflow for a cytological liquid biopsy assay using FNA supernatant specimens” (Maher, M.H., et al., 2025, Cancer Cytopathology) – 2025 | Open Access |
“Dinutuximab synergistically enhances the cytotoxicity of natural killer cells to retinoblastoma through the perforin-granzyme B pathway” (Wang, H., et al., 2020, OncoTargets and Therapy) – 2020 | 8 Citations